Unlisted pharmas improved profitability by reducing SG&A expenses

It was observed that unlisted pharmaceutical companies, where most of them are small and medium companies, were able to raise profitability by reducing ‘selling, general and administrative(SG&A) expenses.’

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2016 audit reports turned by 74 unlisted pharmaceutical companies, their SG&A expense ratio to sales was 34.4% on average....